Cord Tissue Mesenchymal Stromal Cells
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Autism
Conditions
Autism, Autism Spectrum Disorder
Trial Timeline
Oct 12, 2020 → Feb 1, 2024
NCT ID
NCT04089579About Cord Tissue Mesenchymal Stromal Cells
Cord Tissue Mesenchymal Stromal Cells is a phase 2 stage product being developed by Cryo-Cell for Autism. The current trial status is completed. This product is registered under clinical trial identifier NCT04089579. Target conditions include Autism, Autism Spectrum Disorder.
What happened to similar drugs?
0 of 10 similar drugs in Autism were approved
Approved (0) Terminated (2) Active (8)
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04089579 | Phase 2 | Completed |
Competing Products
20 competing products in Autism